Published in Biophys J on March 01, 2001
Bacteriorhodopsin: a light-driven proton pump in Halobacterium Halobium. Biophys J (1975) 12.68
Structure of the light-driven chloride pump halorhodopsin at 1.8 A resolution. Science (2000) 3.93
Halorhodopsin is a light-driven chloride pump. J Biol Chem (1982) 3.24
A model-independent approach to assigning bacteriorhodopsin's intramolecular reactions to photocycle intermediates. Biophys J (1993) 1.77
Millisecond Fourier-transform infrared difference spectra of bacteriorhodopsin's M412 photoproduct. Proc Natl Acad Sci U S A (1987) 1.74
Spectrally silent transitions in the bacteriorhodopsin photocycle. Biophys J (1996) 1.62
Transient spectroscopy of bacterial rhodopsins with an optical multichannel analyzer. 1. Comparison of the photocycles of bacteriorhodopsin and halorhodopsin. Biochemistry (1989) 1.35
Photocycle of halorhodopsin from Halobacterium salinarium. Biophys J (1995) 1.29
Light-driven chloride ion transport by halorhodopsin from Natronobacterium pharaonis. 1. The photochemical cycle. Biochemistry (1995) 1.26
Properties and photochemistry of a halorhodopsin from the haloalkalophile, Natronobacterium pharaonis. J Biol Chem (1990) 1.14
Photoactive retinal pigments in haloalkaliphilic bacteria. J Gen Microbiol (1986) 1.09
Fourier transform infrared study of the halorhodopsin chloride pump. Biochemistry (1988) 1.08
Halide binding by the purified halorhodopsin chromoprotein. I. Effects on the chromophore. J Biol Chem (1984) 1.07
Picosecond events in the photochemical cycle of the light-driven chloride-pump halorhodopsin. Biophys J (1985) 1.06
Evaluation of intrinsic chemical kinetics and transient product spectra from time-resolved spectroscopic data. Biophys Chem (1997) 1.05
Evidence for a halide-binding site in halorhodopsin. J Biol Chem (1983) 1.04
Effect of salt on photocycle and ion-pumping of halorhodopsin and third rhodopsinlike pigment of Halobacterium halobium. Biophys J (1984) 1.03
Chemical reconstitution of a chloride pump inactivated by a single point mutation. EMBO J (1995) 1.01
Specific arginine and threonine residues control anion binding and transport in the light-driven chloride pump halorhodopsin. EMBO J (1997) 1.01
Functional reconstitution of halorhodopsin. Properties of halorhodopsin-containing proteoliposomes. J Biol Chem (1988) 1.00
Anion-protein interactions during halorhodopsin pumping: halide binding at the protonated Schiff base. Biochemistry (1994) 0.98
Infrared spectroscopic detection of light-induced change in chloride-arginine interaction in halorhodopsin. Biochemistry (1994) 0.96
Light-dependent trans to cis isomerization of the retinal in halorhodopsin. FEBS Lett (1984) 0.95
Chloride concentration dependency of the electrogenic activity of halorhodopsin. Biochemistry (1999) 0.95
Structure of the retinal chromophore in the hRL intermediate of halorhodopsin from resonance raman spectroscopy. Biochemistry (1987) 0.94
Resonance Raman study of halorhodopsin photocycle kinetics, chromophore structure, and chloride-pumping mechanism. Biochemistry (1992) 0.94
Transient spectroscopy of bacterial rhodopsins with an optical multichannel analyzer. 2. Effects of anions on the halorhodopsin photocycle. Biochemistry (1989) 0.92
Homologous overexpression of a light-driven anion pump in an archaebacterium. Mol Microbiol (1993) 0.91
Electrostatic interaction between anions bound to site I and the retinal Schiff base of halorhodopsin. Biochemistry (1986) 0.90
Chromophore-anion interactions in halorhodopsin from Natronobacterium pharaonis probed by time-resolved resonance Raman spectroscopy. Biochemistry (1997) 0.90
Nano- and microsecond time-resolved FTIR spectroscopy of the halorhodopsin photocycle. Photochem Photobiol (1997) 0.88
Anion binding to the chloride pump, halorhodopsin, and its implications for the transport mechanism. FEBS Lett (1990) 0.87
Effects of various anions on the Raman spectrum of halorhodopsin. Biophys J (1989) 0.87
Existence of two L photointermediates of halorhodopsin from Halobacterium salinarium, differing in their protein and water FTIR bands. Biochemistry (1999) 0.85
Low-temperature photoreactions of halorhodopsin. 2. Description of the photocycle and its intermediates. Biochemistry (1989) 0.79
Activation parameters for the halorhodopsin photocycle: a phase lifetime spectroscopic study of the 520- and 640-nanometer intermediates. Biochemistry (1990) 0.79
Orientation of the bacteriorhodopsin chromophore probed by polarized Fourier transform infrared difference spectroscopy. Biochemistry (1986) 1.76
Millisecond Fourier-transform infrared difference spectra of bacteriorhodopsin's M412 photoproduct. Proc Natl Acad Sci U S A (1987) 1.74
Structure-function studies on bacteriorhodopsin. IV. Purification and renaturation of bacterio-opsin polypeptide expressed in Escherichia coli. J Biol Chem (1987) 1.31
Proton transfer from Asp-96 to the bacteriorhodopsin Schiff base is caused by a decrease of the pKa of Asp-96 which follows a protein backbone conformational change. Biochemistry (1993) 1.30
Conserved amino acids in F-helix of bacteriorhodopsin form part of a retinal binding pocket. FEBS Lett (1989) 1.21
Kinetic analysis of four HIV-1 reverse transcriptase enzymes mutated in the primer grip region of p66. Implications for DNA synthesis and dimerization. J Biol Chem (1997) 1.12
Fourier transform infrared study of the halorhodopsin chloride pump. Biochemistry (1988) 1.08
Vibrational spectroscopy of bacteriorhodopsin mutants. Evidence for the interaction of aspartic acid 212 with tyrosine 185 and possible role in the proton pump mechanism. J Biol Chem (1990) 1.08
Are C14-C15 single bond isomerizations of the retinal chromophore involved in the proton-pumping mechanism of bacteriorhodopsin? Proc Natl Acad Sci U S A (1986) 1.00
Anion-protein interactions during halorhodopsin pumping: halide binding at the protonated Schiff base. Biochemistry (1994) 0.98
[Strophanthin action on myocardial oxygen consumption in dependence upon the functional capacity of the heart]. Naunyn Schmiedebergs Arch Pharmakol (1969) 0.96
Increase in suicidal thoughts and tendencies. Association with diazepam therapy. JAMA (1968) 0.96
Vibrational spectroscopy of bacteriorhodopsin mutants: chromophore isomerization perturbs tryptophan-86. Biochemistry (1989) 0.96
Pre-steady-state kinetic characterization of RNA-primed initiation of transcription by HIV-1 reverse transcriptase and analysis of the transition to a processive DNA-primed polymerization mode. Biochemistry (1998) 0.95
Structural comparison of metarhodopsin II, metarhodopsin III, and opsin based on kinetic analysis of Fourier transform infrared difference spectra. Biophys J (1992) 0.94
Treatment of hepatic coma with exchange transfusion and peritoneal dialysis. JAMA (1967) 0.93
Evidence for a perturbation of arginine-82 in the bacteriorhodopsin photocycle from time-resolved infrared spectra. Biochemistry (2000) 0.89
Nano- and microsecond time-resolved FTIR spectroscopy of the halorhodopsin photocycle. Photochem Photobiol (1997) 0.88
Adverse reactions with calcium antagonists. Hypertension (1983) 0.87
Intensive dynamic back exercises with or without hyperextension in chronic back pain after surgery for lumbar disc protrusion. A clinical trial. Spine (Phila Pa 1976) (1993) 0.86
Actions of prostaglandin E2 on myocardial mechanics, coronary vascular resistance and oxygen consumption in the guinea-pig isolated heat preparation. Br J Pharmacol (1975) 0.85
Angiopoietin-2 inhibition prevents transplant ischemia-reperfusion injury and chronic rejection in rat cardiac allografts. Am J Transplant (2014) 0.85
Analysis of the polymerization kinetics of homodimeric EIAV p51/51 reverse transcriptase implies the formation of a polymerase active site identical to heterodimeric EIAV p66/51 reverse transcriptase. Biochemistry (1998) 0.83
Increase in the coronary vascular resistance by indomethacin in the isolated guinea pig heart preparation in the absence of changes in mechanical performance and oxygen consumption. Eur J Pharmacol (1976) 0.82
Differences between the photocycles of halorhodopsin and the acid purple form of bacteriorhodopsin analyzed with millisecond time-resolved FTIR spectroscopy. Biophys Chem (1995) 0.82
The effect of platelet-derived growth factor ligands in rat cardiac allograft vasculopathy and fibrosis. Transplant Proc (2006) 0.82
Activin A and activin receptors in thyroid cancer. Thyroid (2001) 0.81
Fourth module of Xenopus interphotoreceptor retinoid-binding protein: activity in retinoid transfer between the retinal pigment epithelium and rod photoreceptors. Curr Eye Res (1998) 0.81
Arginine to glutamine substitutions in the fourth module of Xenopus interphotoreceptor retinoid-binding protein. Mol Vis (1998) 0.81
Expression and characterization of the fourth repeat of Xenopus interphotoreceptor retinoid-binding protein in E. coli. Curr Eye Res (1994) 0.81
Donor simvastatin treatment prevents ischemia-reperfusion and acute kidney injury by preserving microvascular barrier function. Am J Transplant (2013) 0.80
Vibrational spectra of individual millimeter-size membrane patches using miniature infrared waveguides. Biophys J (1997) 0.79
[Dissociation of function and metabolism of the isolated guinea pig heart under the influence of phosphodiesterase inhibitors]. Naunyn Schmiedebergs Arch Pharmakol (1970) 0.79
Clotrimazole as an inhibitor of benzo[a]pyrene metabolite-DNA adduct formation in vitro and of microsomal mono-oxygenase activity. Drug Metab Dispos (1980) 0.79
The bradykinin-induced coronary vasodilation. Evidence for an additional prostacyclin-independent mechanism. Naunyn Schmiedebergs Arch Pharmacol (1979) 0.79
A dose-dependent inhibitory effect of cyclosporine A on obliterative bronchiolitis of rat tracheal allografts. Am J Respir Crit Care Med (1997) 0.78
Differential effects of pharmacological HIF preconditioning of donors versus recipients in rat cardiac allografts. Am J Transplant (2013) 0.77
Cytomegalovirus infection accelerates obliterative bronchiolitis of rat tracheal allografts. Transpl Int (1996) 0.76
Interactions of isoprenaline and prostaglandin E2 with respect to myocardial contractile force, coronary vascular resistance and myocardial oxygen consumption in guinea-pig isolated hearts. Br J Pharmacol (1976) 0.75
Calcium antagonists--future uses. Cardiovasc Drugs Ther (1988) 0.75
[Influence of digitoxin upon Ca uptake in lipid extracts from heart microsomes and mitochondria]. Experientia (1970) 0.75
[The effect of anesthetics on the cardiovascular system]. Klin Anasthesiol Intensivther (1976) 0.75
[Studies on various dosages of PMS and HCG in biotechnical puberty induction in young sows]. Arch Exp Veterinarmed (1977) 0.75
[Studies on the success of insemination after various insemination dates in biotechnical puberty induction of young sows]. Arch Exp Veterinarmed (1977) 0.75
Using attendance as a means of evaluating community mental health programs. Community Ment Health J (1971) 0.75
[Prevention of myocardial infarct using magnesium?]. Dtsch Med Wochenschr (1971) 0.75
[Involvement of basal oxygen consumption, activation of myocardium as well as of hemodynamic parameters in total oxygen consumption of the heart]. Klin Wochenschr (1970) 0.75
[Effect of phosphodiesterase inhibitors on the heart]. Naunyn Schmiedebergs Arch Pharmakol (1969) 0.75
Proceedings: Interactions of isoprenaline and PGE2 on oxygen consumption of isolated guinea pig hearts. Naunyn Schmiedebergs Arch Pharmacol (1975) 0.75
Staff resistance to mental health workers as psychotherapists. Hosp Community Psychiatry (1971) 0.75
[Effect of digitoxigenin and ouabain on mechanical activity and oxygen consumption of isolated heart muscle preparations]. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol (1968) 0.75
Effects of calcium-entry antagonists in hypertension. Clin Exp Hypertens A (1982) 0.75
Activin A and activin receptors in the human thyroid: a link to the female predominance of goiter? Horm Metab Res (2000) 0.75
Effect of graft preservation and acute rejection on hypoxia-inducible factor-1 in rat cardiac allografts. Transplant Proc (2006) 0.75
Trauma malpractice claims related to trauma level designation. Am J Surg (1989) 0.75
[On the effect of strophanthin on myocardial O2 consumption as a function of the initial state]. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol (1968) 0.75
Proceedings: Differential actions on isolated atrial and ventricular myocardium of guinea pig by PGE2. Influence of reserpinization, isoprenaline and variations in (Ca)e. Naunyn Schmiedebergs Arch Pharmacol (1975) 0.75
Revised recommendations on the use of antibiotic prophylaxis. Ont Dent (1997) 0.75
Cell vitality in cartilage tissue culture following excimer laser radiation: an in vitro examination. Lasers Surg Med (1993) 0.75
[Pharmacology and toxicology of local anesthetics]. Klin Anasthesiol Intensivther (1978) 0.75
[Synthesis and testing of potential anti-parkinson agents. 3: Biologically active silicon compounds]. Pharmazie (1982) 0.75
[Effect of adrenalin on the oxygen consumption of arrested guinea pig hearts]. Naunyn Schmiedebergs Arch Pharmakol (1970) 0.75
[Burn-out, commitment, personality and experiences during work and training; survey among psychiatry residents]. Tijdschr Psychiatr (2017) 0.75
[Effect of cardiac glycosides]. Dtsch Med Wochenschr (1972) 0.75
A time-limited group experience with a religious teaching order. J Relig Health (1972) 0.75
A postural drainage tilt-table for home or clinic. Respir Care (1979) 0.75
[Differential effect of calcium and noradrenaline on the oxygen consumption of isolated guinea pig atria]. Pflugers Arch (1970) 0.75
[The nurse anesthetist in the surgical team]. Agnes Karll Schwest Krankenpfleger (1968) 0.75
[Analysis of the calcium compartments in guinea pig hearts under control conditions and under the influence of ouabain (author's transl)]. Naunyn Schmiedebergs Arch Pharmacol (1974) 0.75
Different intracellular cation-content present in right and left ventricle dependent on varying extracellular Ca2+-concentrations. J Mol Cell Cardiol (1979) 0.75
[Effect of temperature on the conformation of native DNA in aqueous solutions of various electrolytes]. Mol Biol (Mosk) (1987) 0.75
[Doppler color echocardiography in the diagnosis of 4 septal perforations complicating anterior myocardial infarction]. Arch Mal Coeur Vaiss (1988) 0.75
[In vitro studies on the effect of digitoxin on the uptake of calcium in lipoid extracts from heart muscle]. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol (1969) 0.75
[The course of ovulation after biotechnical puberty induction in young sows]. Arch Exp Veterinarmed (1977) 0.75
[Cause of haemodynamic side effects of some anaesthetic agents]. Anaesthesist (1972) 0.75
Prostaglandin A2 (PGA2) increases the coronary vascular resistance in the guinea-pig isolated heart preparation. Experientia (1977) 0.75
[Ovulation in gilts following biotechnical puberty induction and followed by ovulation stimulation]. Arch Exp Veterinarmed (1978) 0.75
[Recurrent periorbital swelling - intraorbital foreign body]. Laryngorhinootologie (2011) 0.75
Supported planar germanium waveguides for infrared evanescent-wave sensing. Appl Opt (1997) 0.75
[Clinical experiences with Theo-Caradrin in cardiac insufficiency]. Z Allgemeinmed (1969) 0.75
[Effect of various injection times in ovulation stimulation in gilts following previous biotechnical puberty induction]. Arch Exp Veterinarmed (1978) 0.75
[Problems of measurement technic of surface reproduction of impression materials]. Dtsch Zahnarztl Z (1972) 0.75
[An improved method for simultaneous measurement of oxygen consumption and mechanical activity of isolated muscle preparations]. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol (1968) 0.75
[The effect of various doses HCG on ovulation stimulation in gilts following previous biotechnical puberty induction]. Arch Exp Veterinarmed (1978) 0.75
[Influencing the myocardial oxygen consumption using positive inotropic substances]. Dtsch Med Wochenschr (1970) 0.75
[The effect of drugs on consciousness]. Klin Anasthesiol Intensivther (1979) 0.75
[Compartment analysis of Ca turnover in the isolated guinea pig heart]. Naunyn Schmiedebergs Arch Pharmakol (1970) 0.75
[Modifying factors in carciac glycoside therapy]. Med Klin (1976) 0.75
[Cellular bases of the positive inotropic effect of cardiac glycosides, catecholamines and methylxanthines]. Hippokrates (1970) 0.75
[Drug therapy of neck-shoulder-arm syndrome]. MMW Munch Med Wochenschr (1979) 0.75